ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.50
-1.00 (-1.55%)
At close: Feb 26, 2026
172.53%
Market Cap 3.89B
Revenue (ttm) 36.50M
Net Income (ttm) -79.82M
Shares Out 61.22M
EPS (ttm) -1.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 280,746
Average Volume 490,570
Open 64.50
Previous Close 64.50
Day's Range 62.70 - 66.50
52-Week Range 23.10 - 94.30
Beta 0.47
RSI 46.44
Earnings Date Apr 16, 2026

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. The company was founded in 2014 and is based in Kaohsiung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6748
Full Company Profile

Financial Performance

In 2024, ACRO Biomedical's revenue was 44.23 million, a decrease of -13.38% compared to the previous year's 51.06 million. Losses were -62.09 million, 49.9% more than in 2023.

Financial Statements

News

There is no news available yet.